Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma – An external validation study

8 May 2021

Abstract excerpt

BACKGROUND: We recently identified a diagnostic prediction model based on promoter hypermethylation of eight selected genes in plasma cell-free (cf) DNA, which showed promising results as a diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC). The aim of the present study was to validate this biomarker profile in an external patient cohort and examine any additional effect of serum CA 19-9. METHODS:...

Source

Identifiers

PMID: 33994313
DOI: 10.1016/j.pan.2021.05.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma – An external validation studyPMID 33994313Read ↗

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ DiscoverySemantic proximity Read ↗

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancerSemantic proximity Read ↗

Circulating cell‐free <scp>DNA</scp> methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic CancerSemantic proximity Read ↗

Promoter hypermethylation in plasma‐derived cell‐free DNA as a prognostic marker for pancreatic adenocarcinoma stagingSemantic proximity Read ↗

Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancerSemantic proximity Read ↗

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNASemantic proximity Read ↗

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinomaSemantic proximity Read ↗

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature UpdateSemantic proximity Read ↗

Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosisSemantic proximity Read ↗

Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic CancerSemantic proximity Read ↗

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.